logo
logo

August Bioservices Closes $23.6 Million Series A Extension To Expand U.S. Biopharma Manufacturing Capabilities

May 27, 2021•over 4 years ago

Round Type

series a

Nashville

Description

August Bioservices,LLC, a contract development and manufacturing organization (CDMO) providing drug discovery, development, and pharmaceutical manufacturing services, closed a $23.6 million Series A extension, led by Polaris Partners, who joined existing investor Oak HC/FT. The proceeds will go toward expanding August’s manufacturing capacity and capabilities to advance the technology platforms needed to support production of sterile injectable medications.

Company Information

Company

August Bioservices

Location

Nashville, Arkansas, United States

About

Headquartered in Nashville, TN, August Bioservices, LLC is a high-tech, growth-focused, and innovative provider of Contract Research, Development and Manufacturing services, that plays a crucial role in the global pharmaceutical industry supply chain. For the biotech and pharma companies it serves, August is a US-based outsourcing partner with state-of-the-art instrumentation, industry-leading technical expertise, and decades of finished dose pharmaceutical manufacturing experience. For more information about August’s full line of services: www.augustbio.com. For more information about August’s specialized services: www.augustbiospecializedservices.com.